VCEL

$0.00

(

+0.00%

)
Quote details

stock

Vericel Corp Ord

NASDAQ | VCEL

30.23

USD

+$0.00

(

+0.00%

)

At Close (As of Sep 26, 2025)

$1.51B

Market Cap

213.14

P/E Ratio

0.14

EPS

$63.00

52 Week High

$29.24

52 Week Low

HEALTHCARE

Sector

VCEL Chart

Recent Chart
Price Action

VCEL Technicals

Tags:

VCEL Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $172M
Total Revenue $237M
Cost Of Revenue $65M
Costof Goods And Services Sold $65M
Operating Income $4.5M
Selling General And Administrative $143M
Research And Development $25M
Operating Expenses $168M
Investment Income Net -
Net Interest Income $5.8M
Interest Income $6.4M
Interest Expense $614K
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $5.5M
Income Before Tax $11M
Income Tax Expense $148K
Interest And Debt Expense -
Net Income From Continuing Operations $10M
Comprehensive Income Net Of Tax -
Ebit $11M
Ebitda $17M
Net Income $10M

Revenue & Profitability

Earnings Performance

VCEL Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $433M
Total Current Assets $213M
Cash And Cash Equivalents At Carrying Value $75M
Cash And Short Term Investments $75M
Inventory $17M
Current Net Receivables $61M
Total Non Current Assets $220M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets $6.3M
Intangible Assets Excluding Goodwill $6.3M
Goodwill -
Investments -
Long Term Investments $40M
Short Term Investments $42M
Other Current Assets $18M
Other Non Current Assets -
Total Liabilities $141M
Total Current Liabilities $50M
Current Accounts Payable $24M
Deferred Revenue -
Current Debt -
Short Term Debt $9.3M
Total Non Current Liabilities $90M
Capital Lease Obligations $99M
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $99M
Other Current Liabilities $7M
Other Non Current Liabilities $876K
Total Shareholder Equity $292M
Treasury Stock -
Retained Earnings -$393M
Common Stock $685M
Common Stock Shares Outstanding $52M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow $58M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $4.8M
Capital Expenditures $64M
Change In Receivables -
Change In Inventory -$4.3M
Profit Loss -
Cashflow From Investment -$79M
Cashflow From Financing $19M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income $10M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $172M
Total Revenue $237M
Cost Of Revenue $65M
Costof Goods And Services Sold $65M
Operating Income $4.5M
Selling General And Administrative $143M
Research And Development $25M
Operating Expenses $168M
Investment Income Net -
Net Interest Income $5.8M
Interest Income $6.4M
Interest Expense $614K
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $5.5M
Income Before Tax $11M
Income Tax Expense $148K
Interest And Debt Expense -
Net Income From Continuing Operations $10M
Comprehensive Income Net Of Tax -
Ebit $11M
Ebitda $17M
Net Income $10M

VCEL News

VCEL Profile

Vericel Corp Ord Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Vericel Corporation (VCEL) is a leading commercial-stage biopharmaceutical company focused on innovative cell therapies for the sports medicine and severe burn care sectors in the United States. Headquartered in Cambridge, Massachusetts, Vericel is dedicated to advancing the treatment options for patients through its proprietary products, including MACI® and Epicel®. With a robust commitment to research and development, the company aims to enhance patient outcomes and address unmet medical needs in regenerative medicine. Vericel's portfolio reflects its strategic focus on leveraging cutting-edge science to deliver impactful therapies in niche markets.

DVLT
+30.57%
$1.09
INTC
+4.44%
$35.50
GPUS
+19.56%
$0.45
CGBS
-39.47%
$0.03
DFLI
+38.45%
$0.52
YAAS
-31.07%
$0.06
NEHC
+33.33%
$1.84
NUAI
+33.33%
$1.84
SNAP
-0.72%
$8.27
CJET
+10.63%
$0.17
NVDA
+0.28%
$178.19
F
+3.35%
$12.01
PSTV
+9.60%
$0.61
DNN
-3.14%
$2.77
APLT
+121.34%
$1.24
TSLA
+4.01%
$440.40
RGTI
-2.86%
$31.18
BIAF
+55.13%
$5.29
PLUG
+0.42%
$2.37
CIFR
-1.62%
$11.47
NIO
-5.75%
$7.04
ADAP
+15.74%
$0.14
AAL
-0.70%
$11.31
WOK
-5.22%
$0.08
RIG
+0.94%
$3.19
IONZ
+5.83%
$4.34
TPIC
-45.91%
$0.12
AXDX
-61.36%
$0.03
MRM
+102.75%
$2.94
QBTS
+1.59%
$26.76
VALE
-1.74%
$10.70
IREN
-9.57%
$41.86
BTG
+1.44%
$4.92
BLMZ
+12.51%
$0.20
QUBT
-2.11%
$20.14
MARA
+0.37%
$16.13
KVUE
+1.54%
$16.42
RIOT
+5.67%
$17.69
KDLY
+7.69%
$1.26
AAPL
-0.54%
$255.46
ATCH
-4.22%
$0.79
PLTR
-0.86%
$177.57
SOUN
-2.50%
$15.94
BITF
-5.22%
$2.54
BBD
+0.91%
$3.30
TLRY
-3.36%
$1.14
WBD
-1.36%
$19.51
AMZN
+0.74%
$219.78
FCX
+1.16%
$35.75
BURU
-10.14%
$0.12
BMNR
+1.87%
$50.50
IXHL
-0.01%
$0.59
RMBL
+60.50%
$3.21
RXRX
+1.94%
$4.72
ETHD
-5.95%
$3.95
SHOT
+12.24%
$0.28
GRAB
-2.24%
$6.11
ADD
-25.47%
$0.05
CLSK
-5.32%
$13.68
RAYA
-3.15%
$0.04
RR
+2.68%
$4.20
RIVN
-0.95%
$15.59
ONDS
-1.16%
$7.66
SOFI
-0.49%
$27.98
BULL
+3.55%
$15.16
CVE
+0.39%
$17.77
SRM
+53.27%
$10.30
PFE
+0.67%
$23.76
ACHR
-0.53%
$9.27
IONQ
-3.09%
$67.28
BB
+6.66%
$4.96
JOBY
+1.63%
$16.12
NOK
-0.42%
$4.66
AMD
-1.12%
$159.46
CRWV
-4.98%
$120.34
CLF
+2.48%
$12.37
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
BTE
+2.43%
$2.52
QS
+1.28%
$12.66
WLGS
-5.57%
$0.04
HIMS
+6.43%
$58.40
AQMS
+48.37%
$7.30
ABEV
0.00%
$2.29
MRVL
-0.76%
$83.17
ETWO
0.00%
$3.30
ORCL
-2.70%
$283.45
HBAN
+0.57%
$17.42
HOOD
-0.70%
$121.78
AG
+4.02%
$12.14
NWTN
-15.63%
$2.04
AIIO
-15.63%
$2.04
SDM
-86.40%
$1.85
T
+0.03%
$28.31
OKLO
-7.21%
$110.53
ITUB
+0.55%
$7.24
MU
+0.28%
$157.27
PCG
+3.67%
$14.97
AFMD
-34.94%
$0.18
WULF
-1.27%
$10.83
DVLT
+30.57%
$1.09
INTC
+4.44%
$35.50
GPUS
+19.56%
$0.45
CGBS
-39.47%
$0.03
DFLI
+38.45%
$0.52
YAAS
-31.07%
$0.06
NEHC
+33.33%
$1.84
NUAI
+33.33%
$1.84
SNAP
-0.72%
$8.27
CJET
+10.63%
$0.17
NVDA
+0.28%
$178.19
F
+3.35%
$12.01
PSTV
+9.60%
$0.61
DNN
-3.14%
$2.77
APLT
+121.34%
$1.24
TSLA
+4.01%
$440.40
RGTI
-2.86%
$31.18
BIAF
+55.13%
$5.29
PLUG
+0.42%
$2.37
CIFR
-1.62%
$11.47
NIO
-5.75%
$7.04
ADAP
+15.74%
$0.14
AAL
-0.70%
$11.31
WOK
-5.22%
$0.08
RIG
+0.94%
$3.19
IONZ
+5.83%
$4.34
TPIC
-45.91%
$0.12
AXDX
-61.36%
$0.03
MRM
+102.75%
$2.94
QBTS
+1.59%
$26.76
VALE
-1.74%
$10.70
IREN
-9.57%
$41.86
BTG
+1.44%
$4.92
BLMZ
+12.51%
$0.20
QUBT
-2.11%
$20.14
MARA
+0.37%
$16.13
KVUE
+1.54%
$16.42
RIOT
+5.67%
$17.69
KDLY
+7.69%
$1.26
AAPL
-0.54%
$255.46
ATCH
-4.22%
$0.79
PLTR
-0.86%
$177.57
SOUN
-2.50%
$15.94
BITF
-5.22%
$2.54
BBD
+0.91%
$3.30
TLRY
-3.36%
$1.14
WBD
-1.36%
$19.51
AMZN
+0.74%
$219.78
FCX
+1.16%
$35.75
BURU
-10.14%
$0.12
BMNR
+1.87%
$50.50
IXHL
-0.01%
$0.59
RMBL
+60.50%
$3.21
RXRX
+1.94%
$4.72
ETHD
-5.95%
$3.95
SHOT
+12.24%
$0.28
GRAB
-2.24%
$6.11
ADD
-25.47%
$0.05
CLSK
-5.32%
$13.68
RAYA
-3.15%
$0.04
RR
+2.68%
$4.20
RIVN
-0.95%
$15.59
ONDS
-1.16%
$7.66
SOFI
-0.49%
$27.98
BULL
+3.55%
$15.16
CVE
+0.39%
$17.77
SRM
+53.27%
$10.30
PFE
+0.67%
$23.76
ACHR
-0.53%
$9.27
IONQ
-3.09%
$67.28
BB
+6.66%
$4.96
JOBY
+1.63%
$16.12
NOK
-0.42%
$4.66
AMD
-1.12%
$159.46
CRWV
-4.98%
$120.34
CLF
+2.48%
$12.37
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
BTE
+2.43%
$2.52
QS
+1.28%
$12.66
WLGS
-5.57%
$0.04
HIMS
+6.43%
$58.40
AQMS
+48.37%
$7.30
ABEV
0.00%
$2.29
MRVL
-0.76%
$83.17
ETWO
0.00%
$3.30
ORCL
-2.70%
$283.45
HBAN
+0.57%
$17.42
HOOD
-0.70%
$121.78
AG
+4.02%
$12.14
NWTN
-15.63%
$2.04
AIIO
-15.63%
$2.04
SDM
-86.40%
$1.85
T
+0.03%
$28.31
OKLO
-7.21%
$110.53
ITUB
+0.55%
$7.24
MU
+0.28%
$157.27
PCG
+3.67%
$14.97
AFMD
-34.94%
$0.18
WULF
-1.27%
$10.83

Charts powered by TradingView


Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.